VESPINA LIFESCIENCES
Vespina Lifesciences plans to develop to proof-of-concept a potential compound with the potential to treat certain types of inflammatory diseases including pulmonary indications with poor therapeutic options as well as non-pulmonary inflammatory diseases. The compound was originally discovered and characterized at Denmark-based Neuprozyme Therapeutics ApS. There are upwards of 70,000 patients newly diagnosed with bronchiectasis in the US every year as more than half of the 16+ million patients diagnosed with COPD in the US likely also have concurrent bronchiectasis. There are no approved treatments that specifically address the underlying mechanism of disease.
VESPINA LIFESCIENCES
Industry:
Biopharma Biotechnology Health Care Life Science
Address:
Newark, Delaware, United States
Country:
United States
Status:
Active
Similar Organizations
Flightpath Biosciences
Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases.
Genelabs Technologies
Genelabs Technologies is a biopharmaceutical company engaged in the R&D of therapeutics for the treatment of infectious diseases.
Quadriga BioSciences
Quadriga BioSciences is a pharmaceutical company developing proprietary targeted cancer therapies.
Investors List
TVM Capital Life Science
TVM Capital Life Science investment in Venture Round - Vespina Lifesciences
More informations about "Vespina Lifesciences"
Vespina Lifesciences - Crunchbase Company Profile & Funding
Vespina Lifesciences plans to develop to proof-of-concept a potential compound with the potential to treat certain types of inflammatory diseases including pulmonary indications with poor …See details»
Vespina Lifesciences Inc. - TVM Capital Life Science Venture Capital
Vespina Lifesciences Inc. plans to develop to proof-of-concept a potential best-in-class compound with the potential to treat certain types of inflammatory diseases including pulmonary …See details»
Vespina Lifesciences Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Vespina Lifesciences. Use the PitchBook Platform to explore the full profile.See details»
TVM Life Science Innovation II SCSp Announces …
Vespina Lifesciences Inc. plans to develop to proof-of-concept a potential best-in-class compound with the potential to treat certain types of inflammatory diseases including pulmonary indications with poor therapeutic options as well as non …See details»
About us - TVM Capital Life Science Venture Capital
TVM Capital Life Science has emerged as one of the leading international venture capital firms in the field. TVM strategically refocused in 2012 to best exploit untapped industry potential. To achieve this, we adopted a dual-investment …See details»
Vespina Lifesciences - Funding, Financials, Valuation & Investors
Feb 1, 2021 · Vespina Lifesciences plans to develop a potential compound with the potential to treat certain types of inflammatory diseases.See details»
VESPINA LIFESCIENCES, INC. :: Delaware (US) - OpenCorporates
Free and open company data on Delaware (US) company VESPINA LIFESCIENCES, INC. (company number 4272331), New Castle, DESee details»
Vespina Lifesciences - Updates, News, Events, Signals & Triggers
Feb 1, 2021 · Vespina Lifesciences plans to develop a potential compound with the potential to treat certain types of inflammatory diseases.See details»
Vespina Lifesciences, Inc.:Company Profile & Technical Research ...
Vespina Lifesciences is a company that provides Medicine, Oceanography, Nanotechnology and more. Vespina Lifesciences is headquartered in United States Delaware.See details»
News Archives - TVM Capital Life Science Venture Capital
TVM Life Science Innovation II SCSp Announces Investment in Vespina Lifesciences Inc. Luxembourg, February 1st, 2021 – TVM Life Science Innovation II SCSp today announced the …See details»
TVM Life Science Innovation II: Fund Performance - PitchBook
Oct 27, 2020 · TVM Life Science Innovation II was a 2018 vintage venture capital fund managed by TVM Capital and TVM Capital Life Science. The fund was located in Munich, Germany and …See details»
Venture Round - Vespina Lifesciences - 2021-02-01 - Crunchbase
Feb 1, 2021 · Vespina Lifesciences raised an undisclosed amount on 2021-02-01 in Venture RoundSee details»
9 Top BioPharma Startups & Companies (Delaware)
Vespina Lifesciences plans to develop a potential compound with the potential to treat certain types of inflammatory diseases. Based out of Newark, Delaware, United States Twitter | …See details»
News & Events - TVM Capital Life Science Venture Capital
Get the latest information on TVM and its portfolio companies. Emerging Medtech Summit 2024 – Life Science Intelligence. TVM Capital Life Science will take part in the 24th Annual Biotech in …See details»
Vespina Lifesciences - Crunchbase
Quadriga BioSciences is a pharmaceutical company developing proprietary targeted cancer therapies. Vespina Lifesciences plans to develop a potential compound with the potential to …See details»
Ivan Shaw Ph.D Profile: Contact Information & Network - PitchBook
Shaw served as Chief Executive Officer at Vespina Lifesciences. He has served as the CEO for multiple project-focused companies developing oncology, immunology and neuroscience …See details»
Vespina Lifesciences, Inc. - Patsnap
Discovery Company profile page for Vespina Lifesciences, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Leadership Team - The Org
The leaders of Optina Diagnostics have a long and varied history in the medical and financial industries. Many of them have worked as consultants or engineers in companies such as …See details»
TVM Capital Life Science - Recent News & Activity - Crunchbase
TVM Capital Life Science is a dedicated life science venture capital firm, with offices in Montreal, Canada and Munich, Germany.See details»
Investing in Life Science Innovation - TVM Capital Life Science …
Our mission is to invest in the development of exciting life science products and the growth of companies to become innovative leaders in their market segment. As true partners, we work …See details»